NF2 rs1060503666: Understanding This Genetic Variant
The rs1060503666 variant is a specific genetic change located within the NF2 gene. This gene is associated with neurofibromatosis type 2, a condition characterized by the growth of noncancerous tumors in the nervous system.
What each genotype means
Typical NF2 gene profile
This genotype represents the most common sequence found at this location in the NF2 gene. It is not associated with the loss-of-function mutations that characterize neurofibromatosis type 2.
This is the most common genotype observed across all global populations.
Rare variant carrier
This genotype indicates the presence of a rare variant at this position in the NF2 gene. Because this variant is rare, its specific clinical significance is not fully established, and it should be interpreted in the context of a comprehensive clinical evaluation if symptoms are present.
This genotype is extremely rare and is not typically found in the general population.
Rare variant homozygous
This genotype indicates that both copies of the NF2 gene carry this rare variant. Given the rarity of this change, there is limited scientific evidence to define its specific impact on the function of the merlin protein, and it does not necessarily indicate a diagnosis of neurofibromatosis type 2.
This genotype is exceptionally rare and has not been widely documented in population databases.
What is the rs1060503666 Variant?
The rs1060503666 variant is a specific alteration in the DNA sequence of the NF2 gene, which is located on chromosome 22. In genetics, an rsID (reference SNP cluster ID) is a unique label used by researchers to identify a specific location in the human genome where a single nucleotide polymorphism (SNP) or other small variant may occur. This particular variant is situated within the coding region of the NF2 gene. When a variant occurs in a gene, it can potentially change the instructions the body uses to build proteins. Because the NF2 gene is critical for regulating cell growth, variations in this region are studied closely to understand how they might disrupt normal biological processes. Scientists track these specific locations to better understand the genetic architecture of inherited conditions and tumor predisposition syndromes.
The Role of the NF2 Gene
The NF2 gene provides the essential instructions for producing a protein called merlin, also known as schwannomin. Merlin functions as a tumor suppressor, meaning it acts like a biological brake to prevent cells from dividing too rapidly or in an uncontrolled manner. This protein is primarily active in the nervous system, particularly within Schwann cells, which provide the protective insulation for nerve fibers in the brain and spinal cord. When the NF2 gene is functioning correctly, merlin helps maintain the structural integrity of cells and regulates signaling pathways that control cell proliferation. If the gene contains a pathogenic variant, the resulting merlin protein may be nonfunctional or absent. Without this functional protein, cells can multiply excessively, which is the underlying mechanism that leads to the development of tumors in individuals with neurofibromatosis type 2.
Research and Clinical Associations
Research has established a strong link between pathogenic variants in the NF2 gene and neurofibromatosis type 2, an autosomal dominant disorder. Individuals with this condition are prone to developing multiple nervous system tumors, such as vestibular schwannomas, meningiomas, and ependymomas. The evidence for the association between specific NF2 variants and this clinical presentation is well-documented in medical literature. However, it is important to note that not all variants in a gene have the same impact. While some variants are clearly pathogenic and lead to disease, others may be benign or have uncertain significance. Clinical classification of these variants relies on a combination of population frequency data, functional studies, and family history. Because neurofibromatosis type 2 is a complex condition, genetic testing results should always be interpreted by a qualified healthcare professional or genetic counselor who can provide context based on an individual's specific clinical history.
Population Frequency
The rs1060503666 variant is considered rare in the general population. In genetic studies, rare variants are those that appear at a very low frequency across diverse ancestral groups. Because neurofibromatosis type 2 itself is a relatively uncommon condition, occurring in approximately 1 in 33,000 people worldwide, the specific genetic variants that cause it are also expected to be infrequent. Population databases like gnomAD are used by researchers to determine how often a specific variant appears in healthy individuals. When a variant is found to be extremely rare or absent in large, healthy control populations, it provides stronger evidence that the variant may be linked to a specific health condition. If you have received information about this variant, it is important to remember that population frequency is only one piece of the puzzle and does not replace a formal clinical evaluation.
What You Can Do With This Information
If you have identified this variant through genetic testing, the most important step is to consult with a medical professional, such as a genetic counselor or a specialist in neurogenetics. They can help you understand what this result means in the context of your personal and family health history. It is crucial to avoid self-diagnosis or making medical decisions based solely on raw genetic data. A clinician can determine if the variant is clinically significant and whether further diagnostic testing or surveillance is appropriate. Genetic information is complex, and professional guidance ensures that you receive accurate information tailored to your specific situation. If this variant is associated with a medication response or a specific health risk, your doctor will be able to discuss the best course of action, including any necessary monitoring or management strategies.
How common is this variant?
The rs1060503666 variant is rare in the general population, consistent with its association with a specific genetic condition.
Frequently asked questions
What is neurofibromatosis type 2?
Neurofibromatosis type 2 is a genetic disorder that causes the growth of noncancerous tumors in the nervous system, particularly on the nerves that carry information from the inner ear to the brain.
Does having this variant mean I have a disease?
Not necessarily. Genetic variants must be interpreted by a healthcare professional in the context of your clinical symptoms and family history. Always consult a doctor to understand the implications of your specific genetic results.
How is neurofibromatosis type 2 inherited?
It is typically inherited in an autosomal dominant pattern, meaning one copy of the altered gene in each cell is sufficient to cause the disorder. However, many cases occur due to new, spontaneous mutations in the gene.
Where can I find a genetic counselor?
In the United States, you can find a board-certified genetic counselor through the National Society of Genetic Counselors website. They are trained to help you understand genetic test results and their impact on your health.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1060503666?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29